NOT-HL-23-083 Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities

Funder: NIH Multiple ICs – check FOA for full list

Topics: Co-Morbidities, COVID-19, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Economic Impact, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mobile Health, App, Telemedicine, Research Methods, Electronic Health Records (EHR), Research Site, Community-based, Social Determinants of Health

RFA-OD-23-051 Emergency Award: RADx-®UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COPD, COVID-19, Diabetes, Gastroesophageal Reflux Disease (GERD), Hidradentis Supporativa, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Neurological Disorders, Substance Abuse, Community Engagement, Computational Analysis, Diagnostics, Diagnostics Development, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Health Disparities, Healthcare Implementation, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Occupational Health, Oral Science / Dentistry, Prevention, PPE, Social Distancing, Prognostics, Research Site, Community-based, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population, Children, Deaf Persons, Elderly, Homeless Persons, Pregnant Women, Prisoners, Service Workers, Teens, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Targets

RFA-OD-23-050 Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COPD, COVID-19, Diabetes, Gastroesophageal Reflux Disease (GERD), Hidradentis Supporativa, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Neurological Disorders, Substance Abuse, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Diagnostics, Diagnostics Development, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Health Disparities, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Occupational Health, Oral Science / Dentistry, Prevention, PPE, Social Distancing, Prognostics, Research Site, Community-based, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Research Tool Development, Social Determinants of Health, Target Population, Children, Deaf Persons, Elderly, Homeless Persons, Pregnant Women, Prisoners, Service Workers, Teens, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Targets

NOT-HS-23-013 Special Emphasis Notice: AHRQ Announces Interest in Health Services Research to Advance Health and Healthcare Equity.

Funder: Agency for Healthcare Research and Quality (AHRQ)

Topics: Clinical Presentation of Infection, Long-term Impact of Infection, Co-Morbidities, COVID-19, Education and Training, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation

PAR-23-169 Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

Funder: NIH: National Institute of Allergy and Infectious Diseases (NIAID)

Topics: Co-Morbidities, COVID-19, Immune Disorders, HIV, Immunosuppression, Inflammation, Computational or Data Science Methods Development, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Impact to Conduct of Research, Pandemic Context, Research Facilities Development, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Research Tool Development

RFA-HS-23-012 Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, Person-Centered Care to People with Long COVID (U18)

Funder: HHS Agency for Healthcare Research and Quality

Topics: COVID-19, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Health Disparities, Healthcare Implementation, Mobile Health, App, Telemedicine, Wearables, Occupational Health, Research Site, Community-based, Social Determinants of Health

RFA-NS-24-022 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Presentation of Infection, Long-term Impact of Infection, Co-Morbidities, COVID-19

NOT-HL-23-080 Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy

Funder: NIH: National Heart, Lung, and Blood Institute (NHLBI)

Topics: Biomarkers, Clinical Presentation of Infection, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Co-Morbidities, Cardiovascular Disease, COVID-19, Diabetes, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Community Engagement, Computational or Data Science Methods Development, Epidemiology, Clinical History, Clinical Outcome, Risk Factors, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Organ, Brain, Endocrine, GI, Heart, Cardiovascular, Kidney, Liver, Lung, Prognostics, Research Methods, Cell Culture, Electronic Health Records (EHR), Imaging, Immunofluorescence, Screen, Sequencing, Research Model Development, Research Models, Mouse Models, Non-Human Animal Models, Organoid Models, Virology, Viral Interactome, Viral Proteins, Virus Factors, Research Tool Development

NOT-AA-23-003 Notice of Special Interest: Advancing mHealth Interventions for Understanding and Preventing Alcohol-Related Domestic Violence

Funder: NIH: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Topics: Co-Morbidities, COVID-19, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Health Disparities, Healthcare Implementation, Mental Health, App, Telemedicine, Wearables, Research Site, Community-based, Social Determinants of Health

NOT-DE-23-004 Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)

Funder: NIH: National Institute of Dental and Craniofacial Research (NIDCR)

Topics: Antibody, Biomarkers, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COPD, COVID-19, Gastroesophageal Reflux Disease (GERD), Hidradentis Supporativa, Immune Disorders, HIV, Immunosuppression, Inflammation, Neurological Disorders, Substance Abuse, Computational or Data Science Methods Development, Diagnostics, Economic Impact, Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Risk Factors, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Oral Science / Dentistry, Organ, Oral Cavity, Prevention, Product Development and Commercialization, Prognostics, Research Methods, Cell Culture, Electronic Health Records (EHR), Imaging, Immunofluorescence, Screen, Sequencing, Research Model Development, Research Models, Mouse Models, Non-Human Animal Models, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Research Tool Development, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

RFA-AI-23-021 Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed)

Funder: NIH: National Institute of Allergy and Infectious Diseases (NIAID)

Topics: Computational Analysis, Computational or Data Science Methods Development, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

RFA-AI-23-020 Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed)

Funder: NIH: National Institute of Allergy and Infectious Diseases (NIAID)

Topics: Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

RFA-AI-23-019 Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed)

Funder: NIH: National Institute of Allergy and Infectious Diseases (NIAID)

Topics: Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

NOT-AI-23-036 Pre-Solicitation Notice: External Quality Assurance Program Oversight Laboratory (EQAPOL), RFP: 75N93022R00034

Funder: NIH: National Institute of Allergy and Infectious Diseases (NIAID)

Topics: Virology, Viral Interactome, Viral Proteins, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drug Treatment, Drugs, Antibody-based Treatment, Drug Development, Drug Repurposing, Immunological Response Targets, Anti-viral Targets

RFA-NS-23-022 Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Biomarkers, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, Immune Disorders, Inflammation, Neurological Disorders, Substance Abuse, Computational Analysis, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Transmission, Health Disparities, Immunology, Host Factors, Host Response, Mental Health, Organ, Brain, Prevention, Virology, Viral Interactome, Viral Proteins, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

RFA-NS-23-021 Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Biomarkers, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, Immune Disorders, Inflammation, Neurological Disorders, Substance Abuse, Computational Analysis, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Transmission, Health Disparities, Immunology, Host Factors, Host Response, Mental Health, Organ, Brain, Prevention, Viral Interactome, Viral Proteins, Vaccines, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

NOT-MD-23-008 Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Trial, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Mobile Health, App, Telemedicine, Wearables, Research Site, Community-based, Vaccine Development, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population

RFA-MD-23-004 Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Mobile Health, App, Telemedicine, Wearables, Prevention, PPE, Social Distancing, Research Site, Benioff Children’s Hospital Oakland (BCHO), Community-based, International, Social Determinants of Health, Target Population, Children, Elderly, Homeless Persons, Prisoners, Service Workers, Teens, Visually Impaired

NOT-HD-23-001 Notice of Special Interest (NOSI): Mortality of Adolescents, Young Adults, and Other NICHD Priority Populations in the United States

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Co-Morbidities, COVID-19, Immune Disorders, Immunosuppression, Rheumatoid Disorders, Neurological Disorders, Community Engagement, Diagnostics, Antibody Detection, Diagnostics Development, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Viral Detection, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Mental Health, Mobile Health, App, Telemedicine, Wearables, Oral Science / Dentistry, Organ, Brain, Endocrine, Eye, GI, Heart, Cardiovascular, Kidney, Liver, Lung, Oral Cavity, Skin, Prevention, Research Methods, Electronic Health Records (EHR), Research Site, Benioff Children’s Hospital Oakland (BCHO), Community-based, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population, Children, Deaf Persons, Elderly, Homeless Persons, Pregnant Women, Teens, Visually Impaired, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

NOT-OD-23-040 Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Applied Research, Biomarkers, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Co-Morbidities, COVID-19, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Diagnostics, Antibody Detection, Diagnostics Development, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Viral Detection, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Mobile Health, Product Development and Commercialization, Prognostics, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

NOT-AI-23-012 Notice of Special Interest (NOSI): Complement in Fundamental Immunology

Funder: NIH National Institute of Allergy and Infectious Diseases (NIAID)

Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, Immune Disorders, Inflammation, Community Engagement, Computational Analysis, Health Disparities, Immunity, Immunology

NOT-DA-24-002 Notice of Special Interest (NOSI): Chemsex and HIV: prevalence, medical/psychosocial consequences, and treatment

Funder: NIH National Institute on Drug Abuse

Topics: Co-Morbidities, COVID-19, Immune Disorders, HIV, Immunosuppression, Substance Abuse, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Health Disparities, Target Population, Treatments

NOT-HS-23-003 AHRQ Announces Interest in Healthcare Associated Infections and Combating Antibiotic Resistant Bacteria Research

Funder: HHS Agency for Healthcare Research and Quality

Topics: Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, Epidemiology, Clinical History, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Impact to Conduct of Research, Pandemic Context, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Social Determinants of Health, Target Population, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability

NOT-DA-22-084 Notice of Special Interest (NOSI): Research on the Impact of Policy Changes and Emerging and Evolving Public Health Crises on NIDA Populations of Interest

Funder: NIH National Institute on Drug Abuse

Topics: Co-Morbidities, COVID-19, Substance Abuse, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Health Disparities, Healthcare Implementation, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population, Children, Pregnant Women, Teens

NOT-AI-22-064 Notice of Special Interest (NOSI): Halting Tuberculosis (TB) Transmission

Funder: NIH National Institute of Allergy and Infectious Diseases (NIAID)

Topics: Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, Epidemiology, Incidence, Risk Factors, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Organ, Lung, Prevention, PPE, Social Distancing, Research Site, Benioff Children’s Hospital Oakland (BCHO), International, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population

NOT-HD-22-038 Notice of Special Interest (NOSI): Research on the Impact of Policy Changes and Emerging and Evolving Public Health Crises on NICHD Populations of Interest

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Trial, Co-Morbidities, COVID-19, Substance Abuse, Community Engagement, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical Outcome, Incidence, Risk Factors, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Research Site, Benioff Children’s Hospital Oakland (BCHO), Community-based, Target Population, Children, Deaf Persons, Homeless Persons, Pregnant Women, Prisoners, Teens, Visually Impaired

PAR-22-233 Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COVID-19, Diabetes, Immune Disorders, HIV, Immunosuppression, Rheumatoid Disorders, Neurological Disorders, Substance Abuse, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mental Health, Physician Well-being, Psychology, Resident Well-being, Mobile Health, App, Telemedicine, Wearables, Occupational Health, Oral Science / Dentistry, Research Site, Community-based, Social Determinants of Health

NOT-OD-22-166 Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Social Determinants of Health, Target Population

NOT-DA-23-008 Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Trial, Co-Morbidities, COVID-19, Neurological Disorders, Substance Abuse, Community Engagement, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Occupational Health

NOT-HL-22-025 Notice of Special Interest (NOSI): Respiratory Complications of the Muscular Dystrophies (R01)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Presentation of Infection, ARDS, Long-term Impact of Infection, Clinical Trial, Co-Morbidities, COPD, COVID-19, Neurological Disorders, Community Engagement, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Health Disparities, Healthcare Implementation, Research Model Development, Research Models, Mouse Models, Research Site, Community-based, Social Determinants of Health

NOT-OD-22-167 Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes

Funder: NIH Multiple ICs – check FOA for full list

Topics: Co-Morbidities, COVID-19, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mental Health, Psychology, Social Determinants of Health

NOT-HL-22-030 Notice of Special Interest (NOSI): Studies of Cellular/Molecular Pathobiological Mechanisms of Lung Diseases Using Human 3-Dimensional Cellular Systems (R01)

Funder: NIH National Heart Lung and Blood Institute (NHLBI)

Topics: Biospecimen Science, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Immunity, Immunology, Host Factors, Host Response, Organ, Lung, Prognostics, Research Methods, Research Model Development, Research Models, Organoid Models, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors

PAR-22-167 Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, Diagnostics, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Mobile Health, App, Telemedicine, Wearables, Occupational Health, Oral Science / Dentistry, Prevention, PPE, Social Distancing, Product Development and Commercialization, Prognostics, Research Methods, Electronic Health Records (EHR), Research Site, Community-based, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Treatments

NOT-AA-22-012 Notice of Special Interest: Research on Alcohol and Coronavirus Disease (COVID-19) within the Mission of NIAAA

Funder: NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Topics: Biomarkers, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, Cirrhosis, COVID-19, Neurological Disorders, Substance Abuse, Community Engagement, Diagnostics, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Prevention, PPE, Social Distancing, Prognostics, Vaccine Development, Vaccine Efficacy, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population, Homeless Persons, Prisoners, Service Workers, Treatment Efficacy

NOT-HD-22-003 Notice of Special Interest (NOSI) - Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities

Funder: NIH Multiple ICs – check FOA for full list

Topics: Biomarkers, Biospecimen Science, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COPD, COVID-19, Diabetes, Gastroesophageal Reflux Disease (GERD), Hidradentis Supporativa, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Neurological Disorders, Substance Abuse, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Diagnostics, Antibody Detection, Diagnostics Development, Viral Detection, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Host Response, Impact to Conduct of Research, Pandemic Context, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Occupational Health, Oral Science / Dentistry, Organ, Brain, Endocrine, Eye, GI, Heart, Cardiovascular, Kidney, Liver, Lung, Oral Cavity, Skin, Prevention, PPE, Social Distancing, Product Development and Commercialization, Prognostics, Research Facilities Development, Research Methods, Cell Culture, Electronic Health Records (EHR), Imaging, Immunofluorescence, Screen, Sequencing, Research Model Development, Research Models, Mouse Models, Non-Human Animal Models, Organoid Models, Research Site, Community-based, International, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccines, Vaccine Hesitancy, Research Tool Development, Social Determinants of Health, Target Population, Children, Deaf Persons, Elderly, Homeless Persons, Pregnant Women, Teens, Visually Impaired, Treatments, Drugs, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

NOT-HD-22-002 Notice of Special Interest (NOSI) - Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities

Funder: NIH Multiple ICs – check FOA for full list

Topics: Applied Research, Biomarkers, Biospecimen Science, Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COPD, COVID-19, Diabetes, Gastroesophageal Reflux Disease (GERD), Hidradentis Supporativa, Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Neurological Disorders, Substance Abuse, Community Engagement, Computational Analysis, Diagnostics, Antibody Detection, Diagnostics Development, Diagnostic Efficacy, Diagnostic Reliability, Diagnostic Scalability, Viral Detection, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Immunity, Immunology, Host Factors, Impact to Conduct of Research, Pandemic Context, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Oral Science / Dentistry, Organ, Brain, Endocrine, Eye, GI, Heart, Cardiovascular, Kidney, Liver, Lung, Oral Cavity, Skin, Prevention, PPE, Social Distancing, Prognostics, Research Site, Community-based, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors, Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population, Children, Deaf Persons, Elderly, Homeless Persons, Pregnant Women, Teens, Visually Impaired, Treatments, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Drug Repurposing, Drug Targets, Immunological Response Targets, Anti-viral Targets

NOT-AT-22-004 Notice of Special Interest (NOSI): Dissemination and Implementation Research to Advance Mental, Emotional, and Behavioral Health Preventive Interventions in School Settings

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Trial, Co-Morbidities, COVID-19, Neurological Disorders, Substance Abuse, Community Engagement, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Mental Health, Psychology, Mobile Health, App, Telemedicine, Wearables, Research Site, Community-based, Social Determinants of Health, Target Population, Children, Teens

PAR-22-145 Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Presentation of Infection, Clinical Trial, Co-Morbidities, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Diagnostics, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mobile Health, App, Telemedicine, Wearables, Occupational Health, Oral Science / Dentistry, Prevention, Prognostics, Research Methods, Electronic Health Records (EHR), Research Site, Community-based, Vaccines, Vaccine Hesitancy, Social Determinants of Health, Target Population, Children, Deaf Persons, Elderly, Homeless Persons, Pregnant Women, Prisoners, Service Workers, Teens, Visually Impaired, Treatments

RFA-MH-22-140 Understanding Suicide Risk and Protective Factors among Black Youth (R01 Clinical Trial Not Allowed)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Trial, Co-Morbidities, COVID-19, Community Engagement, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Pandemic Context, Mental Health, Psychology, Mobile Health, Social Distancing, Research Site, Community-based, Social Determinants of Health, Target Population, Children, Teens

PAR-22-137 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Co-Morbidities, COVID-19, Neurological Disorders, Computational Analysis, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Health Disparities, Impact to Conduct of Research, Pandemic Context, Mental Health, Target Population, Children, Teens

PAR-22-138 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Co-Morbidities, COVID-19, Neurological Disorders, Computational Analysis, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Health Disparities, Impact to Conduct of Research, Pandemic Context, Mental Health, Target Population, Children, Teens

NOT-HS-22-010 AHRQ Announces Interest in Health Services Research on Health System and Healthcare Professional Responsiveness to COVID-19

Funder: Agency for Healthcare Research and Quality (AHRQ)

Topics: Oral Science / Dentistry, Prevention, PPE, Social Distancing, Mobile Health, Impact to Conduct of Research, Pandemic Context, Research Site, Community-based, Co-Morbidities, COVID-19, Clinical Trial, Healthcare Implementation, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Epidemiology, Transmission, Aerosol, Surveillance, Risk Factors, Incidence, Contact Tracing, Clinical Outcome, Clinical History, Environmental Health, Community Engagement, Education and Training, Economic Impact, Diagnostics, Social Determinants of Health, Target Population, Children, Deaf Persons, Elderly, Healthcare Workers, Homeless Persons, Pregnant Women, Prisoners, Service Workers, Teens, Visually Impaired, Treatments, Vaccines, Vaccine Hesitancy

PAR-22-097 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Organ, Brain, Immunology, Host Response, Host Factors, Co-Morbidities, Immune Disorders, COVID-19, Neurological Disorders, Health Disparities, Epidemiology, Transmission, Risk Factors, Incidence, Contact Tracing, Clinical Outcome, Clinical History, Social Determinants of Health, Target Population, Children, Teens, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors

PAR-22-098 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Organ, Brain, Immunology, Host Response, Host Factors, Co-Morbidities, Immune Disorders, COVID-19, Neurological Disorders, Health Disparities, Epidemiology, Transmission, Risk Factors, Incidence, Contact Tracing, Clinical Outcome, Clinical History, Social Determinants of Health, Target Population, Children, Teens, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution

NOT-MH-22-100 Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research

Funder: NIH National Institute of Mental Health (NIMH)

Topics: Prevention, PPE, Social Distancing, Mobile Health, Wearables, Telemedicine, App, Mental Health, Immunology, Host Response, Host Factors, Research Site, Community-based, Research Model Development, Research Methods, Prognostics, Immunity, Co-Morbidities, Diabetes, COVID-19, Neurological Disorders, Substance Abuse, Clinical Trial, Clinical Presentation of Infection, Pneumonia, Long-term Impact of Infection, Inflammation, Cellular / Molecular Response, ARDS, Healthcare Implementation, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Epidemiology, Transmission, Aerosol, Surveillance, Risk Factors, Incidence, Contact Tracing, Clinical Outcome, Clinical History, Environmental Health, Community Engagement, Diagnostics, Viral Detection, Diagnostics Development, Diagnostic Efficacy, Diagnostic Scalability, Diagnostic Reliability, Antibody Detection, Social Determinants of Health, Target Population, Children, Elderly, Homeless Persons, Non-Human Animals, Pregnant Women, Teens, Treatments, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Anti-viral Targets, Immunological Response Targets, Drugs, Treatment Efficacy, Treatment Reliability, Treatment Scalability, Vaccines, Vaccine Hesitancy

NOT-HL-23-003 Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy

Funder: NIH National Heart Lung and Blood Institute (NHLBI)

Topics: Organ, Heart, Cardiovascular, Immunology, Host Response, Host Factors, Research Models, Non-Human Animal Models, Organoid Models, Mouse Models, Research Model Development, Research Methods, Sequencing, Screen, Immunofluorescence, Imaging, Cell Culture, Prognostics, Co-Morbidities, Immune Disorders, Inflammation, Immunosuppression, HIV, Rheumatoid Disorders, Diabetes, COVID-19, Cardiovascular Disease, Clinical Trial, Community Engagement, Social Determinants of Health, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Factors

NOT-FD-22-006 FDA Notice of Special Interest (NOSI) to add COVID-19 Capacity Building Grants to PAR-18-604 Vet-LIRN Network Capacity-Building Projects (Vet-LIRN)

Funder: U.S. Food and Drug Administration (FDA)

Topics: Research Models, Non-Human Animal Models, Product Development and Commercialization, Applied Research, Diagnostics, Viral Detection, Diagnostics Development, Diagnostic Efficacy, Diagnostic Scalability, Diagnostic Reliability, Antibody Detection, Target Population, Non-Human Animals

NOT-EY-22-010 Notice of Special Interest (NOSI): Addressing Accessibility Inequities with COVID Home-Based Testing for Individuals with Visual Impairment

Funder: NIH National Eye Institute (NEI)

Topics: Prevention, Mobile Health, Wearables, Telemedicine, App, Research Site, Community-based, Product Development and Commercialization, Co-Morbidities, Clinical Trial, Biospecimen Science, Healthcare Implementation, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Community Engagement, Education and Training, Diagnostics, Viral Detection, Diagnostics Development, Diagnostic Efficacy, Diagnostic Scalability, Diagnostic Reliability, Antibody Detection, Computational Analysis, Social Determinants of Health, Target Population, Visually Impaired

NOT-HL-22-004 Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection

Funder: NIH Multiple ICs – check FOA for full list

Topics: Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors

NOT-HL-22-003 Notice of Special Interest (NOSI): Promoting Fundamental Research on Mitochondrial Involvement in Lung Diseases and Sleep Disorders

Funder: NIH National Heart Lung and Blood Institute (NHLBI)

Topics: Co-Morbidities, Immunity, Immunology, Host Factors, Host Response, Organ, Lung, Research Models, Mouse Models, Organoid Models, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors

NOT-AI-22-013 Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza

Funder: NIH National Institute of Allergy and Infectious Diseases (NIAID)

Topics: Vaccine Development, Vaccine Efficacy, Vaccine Reliability, Vaccine Scalability

NOT-AA-22-002 Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA

Funder: NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Topics: Clinical Presentation of Infection, Cellular / Molecular Response, Long-term Impact of Infection, Co-Morbidities, Cirrhosis, COVID-19, Substance Abuse, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Transmission, Health Disparities, Immunology, Organ, Liver, Prognostics

NOT-HL-22-002 NOSI: Notice of Special Interest: Resilience and Vulnerability following Acute Heart, Lung, Blood, and Sleep Insults in People with HIV (R01, Clinical Trial Not Allowed)

Funder: NIH National Heart Lung and Blood Institute (NHLBI)

Topics: Clinical Presentation of Infection, ARDS, Inflammation, Long-term Impact of Infection, Pneumonia, Co-Morbidities, Asthma, Cardiovascular Disease, COPD, COVID-19, Diabetes, Immune Disorders, HIV, Immunosuppression, Inflammation, Health Disparities, Immunity, Immunology, Host Factors, Host Response, Organ, Brain, Heart, Cardiovascular, Liver, Lung, Social Determinants of Health

PAR-22-064 Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Co-Morbidities, Cancer, Immunosuppression, Inflammation, Education and Training, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mobile Health, Telemedicine, Research Site, Community-based, Social Determinants of Health

PA-21-267 Making Health Care Safer in Ambulatory Care Settings and Long-term Care Facilities (R18)

Funder: Agency for Healthcare Research and Quality (AHRQ)

Topics: Co-Morbidities, COVID-19, Community Engagement, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mobile Health, App, Telemedicine, Wearables, Target Population, Children, Elderly, Homeless Persons

PAR-22-027 Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)

Funder: NIH National Institute on Drug Abuse

Topics: Clinical Trial, Co-Morbidities, COVID-19, Substance Abuse, Community Engagement, Economic Impact, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Clinical Outcome, Risk Factors, Health Disparities, Mental Health, Organ, Brain

PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)

Funder: NIH National Center for Advancing Translational Sciences (NCATS)

Topics: Co-Morbidities, COVID-19, Community Engagement, Environmental Health, Epidemiology, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Social Determinants of Health

NOT-MH-21-330 Notice of Special Interest (NOSI): Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Clinical Trial, Co-Morbidities, COVID-19, Substance Abuse, Community Engagement, Computational Analysis, Computational or Data Science Methods Development, Economic Impact, Education and Training, Digital Learning, ELSI (Ethical, Legal, and Social Implications), Environmental Health, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mobile Health, Research Site, Community-based, Social Determinants of Health

NOT-AI-21-057 Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Trial, Co-Morbidities, COVID-19, Immune Disorders, HIV, Immunosuppression, Inflammation, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Research Site, Community-based, International, Social Determinants of Health

PAR-21-275 The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Co-Morbidities, COVID-19, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Research Site, Community-based, Social Determinants of Health, Target Population, Healthcare Workers, Homeless Persons, Service Workers

NOT-OD-21-092 Notice of Special Interest (NOSI): Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not

Funder: NIH Multiple ICs – check FOA for full list

Topics: Co-Morbidities, COVID-19, Diagnostics, Education and Training, Digital Learning, Health Disparities, Healthcare Implementation, Mobile Health

NOT-HD-21-038 Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities

Funder: NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Topics: Health Disparities, Healthcare Implementation, Mobile Health, Target Population, Children, Deaf Persons, Elderly, Pregnant Women, Teens, Vaccines, Vaccine Hesitancy

PAR-21-248 Pediatric Immune System – Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)

Funder: NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Sensory, Environmental Health, Health Disparities, Immunity, Immunology, Host Factors, Host Response, Oral Science / Dentistry, Social Determinants of Health, Target Population, Children, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors

PAR-21-287 Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Computational or Data Science Methods Development, Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mobile Health, Research Site, Community-based, Social Determinants of Health, Target Population, Children

PA-21-232 Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)

Funder: NIH: Multiple ICs - check FOA for full list

Topics: Co-Morbidities, COVID-19, Diabetes, Community Engagement, Economic Impact, Education and Training, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context

NOT-AA-21-028 NOSI: Public Policy Effects on Alcohol-, Cannabis-, Tobacco-, and Other Drug-Related Behaviors and Outcomes

Funder: NIH Multiple ICs – check FOA for full list

Topics: Co-Morbidities, COVID-19, Neurological Disorders, Substance Abuse, Health Disparities, Healthcare Implementation, Social Determinants of Health, Target Population, Children, Elderly, Homeless Persons, Prisoners, Teens

NOT-HD-21-026 NOSI: Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth

Funder: NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Topics: Co-Morbidities, COVID-19, Neurological Disorders, Substance Abuse, Health Disparities, Healthcare Implementation, Social Determinants of Health, Target Population, Children, Homeless Persons, Teens

NOT-OD-21-100 NOSI: Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health

Funder: NIH Multiple ICs – check FOA for full list

Topics: Community Engagement, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mobile Health, App, Telemedicine, Wearables, Prevention, PPE, Social Distancing, Social Determinants of Health, Vaccines, Vaccine Hesitancy

PAR-20-036 National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional).

Funder: NIH National Institute of Dental and Craniofacial Research (NIDCR)

Topics: Clinical Trial, Co-Morbidities, COVID-19, Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Occupational Health, Oral Science / Dentistry, Organ, Oral Cavity, Prevention, PPE, Social Distancing, Research Model Development, Research Site, Community-based

NOT-DA-21-001 NOSI: Deciphering the Mosaic of Glia in the Addicted Brain.

Funder: NIH National Institute on Drug Abuse

Topics: Clinical Presentation of Infection, Cellular / Molecular Response, Long-term Impact of Infection, Co-Morbidities, COVID-19, Neurological Disorders, Substance Abuse, Organ, Brain

PAR-21-160 NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Funder: NIH National Institute of Dental and Craniofacial Research (NIDCR)

Topics: Clinical Trial, Epidemiology, Clinical History, Clinical Outcome, Risk Factors, Transmission, Oral Science / Dentistry, Organ, Oral Cavity, Prevention

NOT-TR-21-022 Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational science Award (CTSA) Program to Address COVID-19 Public Health Needs

Funder: NIH National Center for Advancing Translational Sciences (NCATS)

Topics: Treatments, Convalescent Serum, Drug Development, Drug Repurposing, Drug Targets, Anti-viral Targets, Immunological Response Targets, Drugs, Treatment Efficacy, Treatment Reliability, Vaccine Development

NOT-DA-21-019 Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders

Funder: NIH National Institute on Drug Abuse (NIDA)

Topics: Healthcare Implementation, Impact to Conduct of Research, Pandemic Context, Mobile Health, App, Wearables

NOT-TR-21-017 Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs

Funder: NIH National Center for Advancing Translational Sciences (NCATS)

Topics: Community Engagement, Computational Analysis, Economic Impact, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Clinical History, Clinical Outcome, Contact Tracing, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Social Determinants of Health

NOT-DA-21-018 Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders

Funder: NIH National Institute on Drug Abuse (NIDA)

Topics: Clinical Presentation of Infection, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Sensory, Co-Morbidities, COVID-19, Immune Disorders, HIV, Immunosuppression, Substance Abuse, Computational Analysis, Health Disparities, Organ, Brain, Prognostics, Social Determinants of Health

NOT-DA-21-017 Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19

Funder: NIH National Institute on Drug Abuse (NIDA)

Topics: Clinical Presentation of Infection, ARDS, Cellular / Molecular Response, Inflammation, Long-term Impact of Infection, Pneumonia, Co-Morbidities, COVID-19, Immune Disorders, HIV, Immunosuppression, Substance Abuse, Computational Analysis, Epidemiology, Clinical History, Clinical Outcome, Risk Factors, Transmission, Immunology, Host Factors, Host Response, Oral Science / Dentistry, Organ, Lung, Prevention

NOT-DA-21-011 Notice of Special Interest (NOSI): Effects of Smoking and Vaping on the Risk and Outcome of COVID-19 Infection

Funder: NIH National Institute on Drug Abuse (NIDA)

Topics: Co-Morbidities, Asthma, Cancer, Cardiovascular Disease, Cirrhosis, COPD, COVID-19, Diabetes, Gastroesophageal Reflux Disease (GERD), Immune Disorders, HIV, Immunosuppression, Inflammation, Rheumatoid Disorders, Substance Abuse, Epidemiology, Clinical History, Clinical Outcome, Incidence, Risk Factors, Surveillance, Transmission, Aerosol, Health Disparities, Target Population, Elderly, Teens

PAR-21-121 Limited Competition Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)

Funder: NIH National Center for Advancing Translational Sciences (NCATS)

Topics: Biospecimen Science, Computational Analysis, Computational or Data Science Methods Development, Mobile Health, Research Model Development, Research Tool Development

NOT-DA-20-084 Notice of Special Interest (NOSI): Effects of Smoking and Vaping on the Risk and Outcome of COVID-19 Infection

Funder: NIH National Institute on Drug Abuse

Topics: Target Population, Teens, Mental Health, Co-Morbidities, Immune Disorders, Immunosuppression, HIV, Diabetes, Cirrhosis, Cardiovascular Disease, Cancer, Substance Abuse, Clinical Presentation of Infection, Epidemiology, Clinical Outcome, Clinical History

NOT-HL-20-814 Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)

Funder: NIH National Heart, Lung and Blood Institute (NHLBI)

Topics: ARDS, Co-Morbidities, Immunology, Host Factors, Host Response, Organ, Lung

PAR-20-298: Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)

Funder: NIH Multiple ICs – check FOA for full list

Topics: Immunology, Target Population, Pregnant Women

PAR-20-303: Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)

Funder: NIH National Cancer Institute

Topics: Co-Morbidities, ELSI (Ethical, Legal, and Social Implications), Health Disparities

PAR-20-302: Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)

Funder: NIH National Cancer Institute

Topics: Co-Morbidities, ELSI (Ethical, Legal, and Social Implications), Health Disparities

NOT-HD-20-021 Notice of Special Interest (NOSI): Emerging Viral Infections and Their Impact on the Male and Female Reproductive Tract

Funder: NIH Multiple ICs – check FOA for full list

Topics: Clinical Presentation of Infection, Organ, Research Methods, Organoid Models, Virology, Viral Interactome, Viral Proteins, Virus Biology, Virus Evolution, Virus Factors

PAR-20-297: NIOSH Centers of Excellence for Total Worker Health (U19)

Funder: CDC/NIOSH

Topics: Mental Health, Physician Well-being, Psychology, Resident Well-being, Target Population, Healthcare Workers, Service Workers

PAR-20-238 Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Funder: NIH: Multiple ICs - check FOA for full list

Topics: Community Engagement, ELSI (Ethical, Legal, and Social Implications), Health Disparities, Healthcare Implementation, Target Population

NOT-DA-20-058: Notice of Special Interest (NOSI): Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders

Funder: NIH: National Institute on Drug Abuse (NIDA)

Topics: Co-Morbidities, Healthcare Implementation, Mobile Health, Telemedicine, Research Tool Development, Target Population